AC IMMUNE SA SF-02 (IMR) — Net Asset Quality Index
AC IMMUNE SA SF-02 (IMR) has a Net Asset Quality Index of 23.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €150.40 Million minus total liabilities of €115.23 Million yields net assets of €35.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of AC IMMUNE SA SF-02 for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
AC IMMUNE SA SF-02 Net Asset Quality Index Over Time (2021–2025)
This chart shows how AC IMMUNE SA SF-02's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 23.4%, representing net assets of €35.17 Million against total assets of €150.40 Million EUR. For live market cap and overall valuation, see IMR stock market capitalisation.
Annual Net Asset Quality Index for AC IMMUNE SA SF-02 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check IMR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.1% | €44.88 Million | €154.25 Million | €109.37 Million | ▼ -19.5 pp |
| 2024 | 48.6% | €112.27 Million | €230.91 Million | €118.64 Million | ▼ -39.3 pp |
| 2023 | 87.9% | €160.64 Million | €182.81 Million | €22.17 Million | ▼ -3.0 pp |
| 2022 | 90.9% | €168.99 Million | €185.94 Million | €16.95 Million | ▲ +2.2 pp |
| 2021 | 88.7% | €231.98 Million | €261.44 Million | €29.46 Million | — |